Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated Myelopathy
Phase: N/A
Priority: Normal
Start: 02/29/12
End: 09/30/16
Due: 09/30/17
Phase: N/A
Priority: Normal
Start: 12/04/18
End: 12/31/22
Due: 12/31/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated Myelopathy | NCT01561755 | David M. Simpson | user2@example.com | None | 2012-02-29 | 2016-09-30 | 2017-09-30 | - | - | 2025-07-14 |
| A Cross Over Pilot Study of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb Tremor | NCT03136341 | David M. Simpson | user2@example.com | None | 2018-12-04 | 2022-12-31 | 2023-12-31 | - | - | 2025-07-14 |